Nanion is again nominated for a prestigious innovation award, due its impressive product portfolio of automated patch clamp systems. More than 350 companies competed in this year's Innovation Award and Nanion is finalist in the category "Start-Up Companies".
The German Industry's Innovation Award, also the world's first innovation award, has since 1980 annually nominated and rewarded the nation's most important scientific and technical innovations. Nanion is one of the five remaining candidates for the award and the winner will be announced on January 24th, 2009.
"To remain a profitable and leading provider of advanced and high quality ion channel drug screening systems, we constantly seek new inventions and solutions that are attractive to industrial and academic institutions." says Michael George, CTO of Nanion.
Dr. Niels Fertig, CEO of Nanion, continues "Our three product families for sophisticated cell analysis are being used in the development of new medicines as well as in academic research. With the latest introduction of our high throughput patch clamp system, the SyncroPatch 96, the screening of ion channel drugs is revolutionized in terms of time and cost efficiency. We are happy and honoured that our products and technology are receiving such recognition by the nomination for this award."
The SyncroPatch 96 is Nanion's next generation screening platform, capable of highly parallel recordings from up to 96 cells at a time. It will be launched at the Biophysical Society's Annual Meeting in Boston, MA, USA, in the end of February, 2009. The SyncroPatch 96 is the first platform on the market to date that supports giga-seal recordings at a throughput of 5000 data points per day.